Status:
COMPLETED
The Use of Wearable Technology to Acquire Signals for COPD Research
Lead Sponsor:
Royal Free Hospital NHS Foundation Trust
Collaborating Sponsors:
Imperial College London
Acurable Ltd.
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18-80 years
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition which affects approximately 3 million people in the UK and 210 million worldwide. The disease is characterized by progressive ai...
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) is a condition characterised by progressive air-flow obstruction, decline in lung function caused by airway inflammation and damaging of air sacs. The resu...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- • Patients with a diagnosis of COPD (FEV1:FVC \<0.7)
- Exclusion Criteria:
- Age \< 18 or \>80years
- Subjects who are not fluent in English, or who have special communication needs.
- Known allergy to the adhesive dressing.
- For the stable patients, subjects with physical or mental impairments who would not be able to use the new technology on their own.
- Subjects with very loose/saggy skin in the neck area which would unavoidably result in the device swinging if moving the neck.
- Subjects with implantable devices
- Subjects with known sleep disordered breathing
- Subjects with stridor
- Subjects requiring ventilation
- Subjects unable to give consent
Exclusion
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT04495062
Start Date
September 1 2020
End Date
August 31 2023
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Respiratory Department Royal Free Hospital NHS Foundation Trust
London, United Kingdom, NW3 2QG